Mark D. Siegel, MD

Yale UniversityNew Haven, Connecticut - 06504 ((203) 688-7987) |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS2
- SINCE2009

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
April 2009 - December 2011
Respiratory Distress Syndrome, Adult
Sepsis
Placebo
Alt-836



